SECTION I CARDIOVASCULAR DISEASE |
|
1 | (110) |
|
Structure and Function of the Normal Heart and Blood Vessels |
|
|
3 | (7) |
|
|
3 | (1) |
|
Electrical Conduction System |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
6 | (2) |
|
Physiology of the Coronary Circulation |
|
|
8 | (1) |
|
Physiology of the Systemic Circulation |
|
|
8 | (1) |
|
Physiology of the Pulmonary Circulation |
|
|
9 | (1) |
|
Cardiovascular Response to Exercise |
|
|
9 | (1) |
|
Cardiovascular Physiology During Pregnancy |
|
|
9 | (1) |
|
|
9 | (1) |
|
Evaluation of the Patient with Cardiovascular Disease |
|
|
10 | (10) |
|
|
10 | (3) |
|
Arterial Pressure and Pulses |
|
|
13 | (1) |
|
Examination of the Neck Veins |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (2) |
|
|
17 | (2) |
|
|
19 | (1) |
|
Special Tests and Procedures in the Patient with Cardiovascular Disease |
|
|
20 | (13) |
|
|
20 | (1) |
|
|
20 | (2) |
|
|
22 | (5) |
|
Long-Term Ambulatory ECG Recording |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (1) |
|
|
30 | (3) |
|
|
33 | (7) |
|
Evaluation and Treatment of Patients with Heart Failure |
|
|
34 | (2) |
|
|
36 | (1) |
|
|
36 | (1) |
|
|
37 | (1) |
|
|
37 | (1) |
|
Cardiovascular Assist Devices |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
40 | (5) |
|
|
40 | (1) |
|
|
40 | (2) |
|
|
42 | (1) |
|
|
42 | (1) |
|
Ventricular Septal Defect |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
General Considerations in the Evaluation and Management of Adults with Congenital Heart Disease |
|
|
44 | (1) |
|
Acquired Valvular Heart Disease |
|
|
45 | (8) |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
46 | (2) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
Pulmonic Stenosis and Regurgitation |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
51 | (2) |
|
|
53 | (16) |
|
|
53 | (1) |
|
|
53 | (1) |
|
Nonatherosclerotic Causes of Coronary Artery Obstruction |
|
|
54 | (1) |
|
Nonobstructive Causes of Ischemic Heart Disease |
|
|
54 | (1) |
|
Pathophysiology of Ischemic Heart Disease |
|
|
54 | (1) |
|
|
55 | (2) |
|
Medical Management of Angina |
|
|
57 | (2) |
|
Coronary Bypass Surgery and Coronary Angioplasty for Angina Pectoris |
|
|
59 | (1) |
|
|
60 | (1) |
|
Acute Myocardial Infarction |
|
|
61 | (2) |
|
Treatment of Acute Myocardial Infarction |
|
|
63 | (1) |
|
Thrombolytic Therapy and Primary Coronary Angioplasty for Acute Myocardial Infarction |
|
|
63 | (2) |
|
|
65 | (1) |
|
Non-Q Wave Myocardial Infarction |
|
|
65 | (1) |
|
Complications of Myocardial Infarction and Their Management |
|
|
66 | (3) |
|
|
69 | (25) |
|
Mechanisms of Arrhthymogenesis |
|
|
69 | (2) |
|
Approach to the Patient with Suspected or Confirmed Arrhythmias |
|
|
71 | (1) |
|
Management of Cardiac Arrhythmias |
|
|
72 | (8) |
|
|
80 | (12) |
|
Principles of Cardiopulmonary Resuscitation |
|
|
92 | (2) |
|
Myocardial and Pericardial Disease |
|
|
94 | (6) |
|
|
94 | (2) |
|
|
96 | (4) |
|
Cardiac Tumors and Trauma |
|
|
100 | (2) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
Aortic and Peripheral Vascular Disease |
|
|
102 | (5) |
|
|
102 | (1) |
|
|
102 | (1) |
|
|
102 | (1) |
|
Miscellaneous Aortic Disease |
|
|
103 | (1) |
|
Peripheral Vascular Disease |
|
|
103 | (2) |
|
Peripheral Aneurysms and Fistulas |
|
|
105 | (1) |
|
|
105 | (1) |
|
Peripheral Venous Disease |
|
|
105 | (1) |
|
|
106 | (1) |
|
|
107 | (4) |
|
|
107 | (1) |
|
|
107 | (1) |
|
|
108 | (3) |
Section II RESPIRATORY DISEASE |
|
111 | (54) |
|
Approach to the Patient with Respiratory Disease |
|
|
113 | (4) |
|
Common Presenting Complaints |
|
|
113 | (1) |
|
|
114 | (3) |
|
Anatomic and Physiologic Considerations |
|
|
117 | (9) |
|
|
117 | (1) |
|
|
117 | (4) |
|
|
121 | (2) |
|
|
123 | (1) |
|
|
124 | (1) |
|
Growth and Aging of the Normal Lung |
|
|
124 | (1) |
|
Nonrespiratory Functions of the Lung |
|
|
125 | (1) |
|
Diagnostic Techniques and their Indications |
|
|
126 | (5) |
|
|
126 | (1) |
|
Pulmonary Function Evaluation |
|
|
126 | (5) |
|
|
131 | (9) |
|
Pathophysiology of Airway Obstruction |
|
|
131 | (1) |
|
|
132 | (1) |
|
Chronic Obstructive Pulmonary Disease (COPD) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
137 | (1) |
|
|
137 | (1) |
|
|
138 | (1) |
|
Physical Therapy and Rehabilitation |
|
|
138 | (1) |
|
Volume Reduction Surgery and Lung Transplantation |
|
|
138 | (2) |
|
Diffuse Infiltrative Diseases of the Lung |
|
|
140 | (6) |
|
|
140 | (1) |
|
|
140 | (5) |
|
|
145 | (1) |
|
Pulmonary Vascular Disease |
|
|
146 | (4) |
|
Physiologic Effects of Pulmonary Hypertension |
|
|
146 | (1) |
|
Causes of Pulmonary Hypertension |
|
|
146 | (1) |
|
|
146 | (3) |
|
Primary Pulmonary Hypertension |
|
|
149 | (1) |
|
Disorders of the Pleural Space, Mediastinum, and Chest Wall |
|
|
150 | (5) |
|
|
150 | (2) |
|
|
152 | (1) |
|
|
153 | (2) |
|
Neoplastic Diseases of the Lung |
|
|
155 | (4) |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
156 | (1) |
|
Solitary Pulmonary Nodule |
|
|
157 | (1) |
|
|
158 | (1) |
|
Control of Breathing in Disease States |
|
|
159 | (3) |
|
|
159 | (2) |
|
Breathing Pattern Abnormalities Associated with Neurologic Disease |
|
|
161 | (1) |
|
|
161 | (1) |
|
Inhalational and Environmental Injury |
|
|
162 | (3) |
|
Drowning and Near-Drowning |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
163 | (1) |
|
|
163 | (2) |
Section III PULMONARY CRITICAL CARE |
|
165 | (8) |
|
Essentials of Pulmonary Critical Care Medicine |
|
|
167 | (6) |
|
|
167 | (1) |
|
Acute Respiratory Failure |
|
|
168 | (1) |
|
Oxygen Therapy and Mechanical Ventilation |
|
|
168 | (2) |
|
Multiple Organ Dysfunction Syndrome, Systemic Inflammatory Response Syndrome, Sepsis, and Adult Respiratory Distress Syndrome |
|
|
170 | (3) |
Section IV RENAL DISEASE |
|
173 | (80) |
|
Elements of Renal Structure and Function |
|
|
175 | (8) |
|
Elements of Renal Structure |
|
|
175 | (2) |
|
Elements of Renal Physiology |
|
|
177 | (4) |
|
Renal Homeostatic Functions |
|
|
181 | (2) |
|
Approach to the Patient with Renal Disease |
|
|
183 | (5) |
|
Clinical Assessment of the Patient with Renal Disease |
|
|
183 | (2) |
|
The Major Renal Syndromes |
|
|
185 | (1) |
|
Anatomic Imaging of the Urinary Tract |
|
|
186 | (2) |
|
Fluid and Electrolyte Disorders |
|
|
188 | (17) |
|
|
188 | (3) |
|
|
191 | (1) |
|
|
192 | (2) |
|
|
194 | (1) |
|
Disturbances in Potassium Balance |
|
|
195 | (3) |
|
Disturbances in Acid-Base Balance |
|
|
198 | (7) |
|
|
205 | (12) |
|
|
205 | (1) |
|
Mechanisms of Glomerular Injury |
|
|
205 | (1) |
|
Clinical Manifestations of Glomerular Disease |
|
|
205 | (1) |
|
Approach to the Patient with Glomerular Disease |
|
|
206 | (1) |
|
|
207 | (1) |
|
Rapidly Progressive Glomerulonephritis (RPGN) |
|
|
208 | (1) |
|
|
209 | (5) |
|
Asymptomatic Urinary Abnormalities |
|
|
214 | (2) |
|
Chronic Glomerulonephritis (CGN) |
|
|
216 | (1) |
|
Major Nonglomerular Disorders |
|
|
217 | (10) |
|
Tubulointerstitial Nephropathy |
|
|
217 | (3) |
|
Cystic Diseases of the Kidney |
|
|
220 | (1) |
|
Urinary Tract Obstruction |
|
|
221 | (1) |
|
|
222 | (2) |
|
|
224 | (3) |
|
Hypertension and Vascular Disorders of the Kidney |
|
|
227 | (8) |
|
|
227 | (4) |
|
Vascular Disorders of the Kidney |
|
|
231 | (4) |
|
|
235 | (8) |
|
|
235 | (1) |
|
Differential Diagnosis and Diagnostic Evaluation of the Patient |
|
|
235 | (3) |
|
Clinical Presentation, Complications, and Management of Acute Tubular Necrosis |
|
|
238 | (2) |
|
Specific Causes of Acute Renal Failure |
|
|
240 | (3) |
|
|
243 | (10) |
|
Adaptation to Nephron Loss |
|
|
243 | (2) |
|
Clinical Manifestations of Renal Failure |
|
|
245 | (3) |
|
|
248 | (5) |
Section V GASTROINTESTINAL DISEASE |
|
253 | (66) |
|
The Common Clinical Manifestations of Gastrointestinal Disease |
|
|
255 | (21) |
|
|
255 | (3) |
|
Gastrointestinal Hemorrhage |
|
|
258 | (4) |
|
|
262 | (7) |
|
|
269 | (7) |
|
Radiographic and Endoscopic Procedures in Gastroenterology |
|
|
276 | (6) |
|
|
276 | (3) |
|
|
279 | (3) |
|
Diseases of the Esophagus |
|
|
282 | (6) |
|
Normal Esophageal Physiology |
|
|
282 | (1) |
|
Clinical Symptoms of Esophageal Disease |
|
|
282 | (1) |
|
Gastroesophageal Reflux Disease |
|
|
283 | (2) |
|
Motility Disorders of the Oropharynx and Esophagus |
|
|
285 | (1) |
|
Other Esophageal Disorders |
|
|
286 | (2) |
|
Diseases of the Stomach and Duodenum |
|
|
288 | (11) |
|
Normal Gastric Physiology |
|
|
288 | (2) |
|
|
290 | (1) |
|
Peptic Ulcer Disease of the Stomach and Duodenum |
|
|
291 | (5) |
|
The Zollinger-Ellison Syndrome |
|
|
296 | (1) |
|
Abnormalities of Gastric Emptying |
|
|
297 | (2) |
|
Inflammatory Bowel Disease |
|
|
299 | (6) |
|
|
299 | (1) |
|
Etiology and Pathogenesis |
|
|
299 | (1) |
|
|
299 | (1) |
|
|
300 | (1) |
|
|
301 | (1) |
|
|
301 | (2) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
304 | (1) |
|
Neoplasms of the Gastrointestinal Tract |
|
|
305 | (7) |
|
Carcinoma of the Esophagus |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
307 | (2) |
|
Polyps of the Gastrointestinal Tract |
|
|
309 | (1) |
|
The Familial Polyposis Syndromes |
|
|
310 | (2) |
|
|
312 | (7) |
|
Normal Structure and Function |
|
|
312 | (1) |
|
|
313 | (2) |
|
|
315 | (2) |
|
Carcinoma of the Pancreas |
|
|
317 | (2) |
Section VI DISEASES OF THE LIVER AND BILIARY SYSTEM |
|
319 | (34) |
|
Laboratory Tests in Liver Disease |
|
|
321 | (2) |
|
Clinical Approach to Liver Disease |
|
|
321 | (1) |
|
Laboratory Tests of Liver Function and Disease |
|
|
321 | (1) |
|
Tests of Hepatic Function |
|
|
321 | (1) |
|
Screening Tests of Hepatobiliary Disease |
|
|
321 | (2) |
|
|
323 | (1) |
|
|
323 | (6) |
|
|
324 | (1) |
|
|
324 | (1) |
|
Laboratory Tests for Bilirubin |
|
|
324 | (1) |
|
Clinical Classification of Jaundice |
|
|
324 | (3) |
|
Approach to the Diagnosis of Jaundice |
|
|
327 | (2) |
|
Acute and Chronic Hepatitis |
|
|
329 | (8) |
|
|
329 | (1) |
|
|
329 | (6) |
|
|
335 | (2) |
|
Fulminant Hepatic Failure |
|
|
337 | (2) |
|
|
337 | (1) |
|
|
337 | (1) |
|
|
338 | (1) |
|
|
338 | (1) |
|
Cirrhosis of the Liver and its Complications |
|
|
339 | (6) |
|
|
339 | (1) |
|
Clinical and Laboratory Features |
|
|
339 | (1) |
|
Specific Causes of Cirrhosis |
|
|
339 | (1) |
|
Major Complications of Cirrhosis |
|
|
340 | (4) |
|
|
344 | (1) |
|
Neoplastic, Infiltrative, and Vascular Diseases of the Liver |
|
|
345 | (3) |
|
|
345 | (1) |
|
|
346 | (1) |
|
Granulomatous Liver Disease |
|
|
346 | (1) |
|
Vascular Disease of the Liver |
|
|
347 | (1) |
|
Disorders of the Gallbladder and Biliary Tract |
|
|
348 | (5) |
|
Normal Biliary Physiology |
|
|
348 | (1) |
|
Pathophysiology of Gallstone Formation (Cholelithiasis) |
|
|
348 | (1) |
|
Clinical Manifestations of Gallstones |
|
|
349 | (4) |
Section VII HEMATOLOGIC DISEASE |
|
353 | (70) |
|
The Blood and Bone Marrow |
|
|
355 | (3) |
|
|
355 | (1) |
|
|
355 | (3) |
|
Disorders of the Hematopoietic Stem Cell |
|
|
358 | (9) |
|
The Myeloaplastic Disorders |
|
|
358 | (1) |
|
The Myelodysplastic Disorders |
|
|
359 | (3) |
|
Myeloproliferative Disorders |
|
|
362 | (2) |
|
|
364 | (3) |
|
|
367 | (10) |
|
|
367 | (1) |
|
Localization of Lymphocytes |
|
|
368 | (1) |
|
Disorders of the Lymphatic System |
|
|
369 | (5) |
|
|
374 | (3) |
|
Disorders of Granulocytes and Monocytes |
|
|
377 | (4) |
|
Neutrophil Structure and Function |
|
|
377 | (1) |
|
Monocyte Structure and Function |
|
|
378 | (1) |
|
|
378 | (1) |
|
|
379 | (1) |
|
|
380 | (1) |
|
|
381 | (17) |
|
Shape and Structure of Red Cells |
|
|
381 | (1) |
|
Birth and Death of Red Cells |
|
|
381 | (1) |
|
|
381 | (17) |
|
Transfusion and Bone Marrow Transplantation |
|
|
398 | (5) |
|
|
398 | (3) |
|
Allogeneic Bone Marrow Transplantation (BMT) |
|
|
401 | (2) |
|
Platelets and Primary Hemostasis |
|
|
403 | (8) |
|
|
403 | (1) |
|
Quantitative Platelet Disorders |
|
|
404 | (3) |
|
|
407 | (1) |
|
Qualitative Platelet Disorders |
|
|
408 | (1) |
|
|
408 | (1) |
|
Plasma Protein Disorders Affecting Primary Hemostasis |
|
|
409 | (2) |
|
Blood Coagulation and its Disorders |
|
|
411 | (12) |
|
Secondary Hemostasis and Clot Stabilization |
|
|
411 | (5) |
|
|
416 | (1) |
|
Natural Anticoagulants and the Fibrinolytic Pathway |
|
|
416 | (1) |
|
Primary Hypercoagulable States |
|
|
417 | (2) |
|
Secondary Hypercoagulable States |
|
|
419 | (1) |
|
Therapy of Thromboembolic Disease |
|
|
419 | (4) |
Section VIII ONCOLOGIC DISEASE |
|
423 | (18) |
|
General Considerations in Oncology |
|
|
425 | (7) |
|
|
425 | (3) |
|
Screening for Early Cancer Detection |
|
|
428 | (1) |
|
Systemic Effects of Cancer |
|
|
429 | (3) |
|
Principles of Cancer Therapy |
|
|
432 | (6) |
|
|
432 | (1) |
|
Principles of Oncologic Surgery |
|
|
432 | (1) |
|
Principles of Radiation Therapy |
|
|
433 | (1) |
|
Principles of Chemotherapy |
|
|
434 | (2) |
|
|
436 | (1) |
|
Biologic Response Modifiers |
|
|
436 | (2) |
|
|
438 | (3) |
|
|
438 | (1) |
|
|
438 | (2) |
|
Increased Intracranial Pressure |
|
|
440 | (1) |
|
Superior Vena Cava Syndrome |
|
|
440 | (1) |
Section IX METABOLIC DISEASE |
|
441 | (34) |
|
Introduction to Metabolic Disease |
|
|
443 | (2) |
|
|
445 | (6) |
|
|
445 | (2) |
|
Anorexia Nervosa and Bulimia Nervosa |
|
|
447 | (4) |
|
Principles of Nutritional Support in Adult Patients |
|
|
451 | (3) |
|
|
451 | (1) |
|
Route of Nutritional Support |
|
|
451 | (1) |
|
|
451 | (1) |
|
|
451 | (2) |
|
|
453 | (1) |
|
|
453 | (1) |
|
|
454 | (4) |
|
|
454 | (1) |
|
Mechanisms of Hyperuricemia |
|
|
454 | (1) |
|
Pathogenesis of Gout Arthritis |
|
|
454 | (1) |
|
Pathogenesis of Renal Disease |
|
|
454 | (1) |
|
|
455 | (1) |
|
|
455 | (1) |
|
|
456 | (2) |
|
Disorders of Lipid Metabolism |
|
|
458 | (6) |
|
Plasma Lipoprotein Physiology |
|
|
458 | (1) |
|
Evaluation of Serum Lipoprotein Concentrations |
|
|
458 | (1) |
|
Elevated Chylomicrons, VLDL, and IDL |
|
|
459 | (1) |
|
Treatment of Hypertriglyceridemia |
|
|
460 | (2) |
|
|
462 | (1) |
|
Treatment of Hypercholesterolemia |
|
|
462 | (1) |
|
Lipids and Vascular Disease |
|
|
463 | (1) |
|
Disorders of Metals and Metalloproteins |
|
|
464 | (6) |
|
|
464 | (1) |
|
|
465 | (1) |
|
|
466 | (4) |
|
Disorders of Amino Acid Metabolism |
|
|
470 | (3) |
|
|
470 | (1) |
|
|
470 | (3) |
|
Inherited Disorders of Connective Tissue |
|
|
473 | (2) |
|
|
473 | (1) |
|
|
473 | (1) |
|
|
473 | (1) |
|
|
474 | (1) |
Section X ENDOCRINE DISEASE |
|
475 | (78) |
|
Hypothalamic-Pituitary Axis |
|
|
477 | (10) |
|
|
477 | (1) |
|
Anterior Pituitary Hormone Physiology and Testing |
|
|
477 | (3) |
|
Neuroradiologic Evaluation of the Pituitary |
|
|
480 | (1) |
|
Pituitary and Hypothalamic Disorders |
|
|
481 | (1) |
|
|
481 | (1) |
|
|
481 | (1) |
|
|
482 | (1) |
|
|
483 | (2) |
|
The Posterior Pituitary Gland |
|
|
485 | (1) |
|
|
485 | (1) |
|
|
486 | (1) |
|
|
487 | (10) |
|
Thyroid Hormone Physiology |
|
|
487 | (1) |
|
|
488 | (1) |
|
|
489 | (1) |
|
|
490 | (1) |
|
|
491 | (1) |
|
Toxic Multinodular Goiter |
|
|
491 | (1) |
|
|
491 | (1) |
|
|
492 | (1) |
|
Rare Causes of Thyrotoxicosis |
|
|
492 | (1) |
|
|
492 | (2) |
|
|
494 | (1) |
|
|
494 | (1) |
|
|
495 | (2) |
|
|
497 | (12) |
|
|
497 | (1) |
|
|
498 | (3) |
|
Hyporeninemic Hypoaldosteronism |
|
|
501 | (1) |
|
Congenital Adrenal Hyperplasia |
|
|
501 | (1) |
|
Syndromes of Adrenocorticoid Hyperfunction |
|
|
502 | (7) |
|
Female Reproductive Endocrinology |
|
|
509 | (10) |
|
Normal Sexual Development |
|
|
509 | (1) |
|
|
509 | (2) |
|
|
511 | (3) |
|
|
514 | (3) |
|
|
517 | (1) |
|
|
517 | (1) |
|
Premenstrual Syndrome (PMS) |
|
|
517 | (1) |
|
|
518 | (1) |
|
Cancer of the Breast, Cervix, Uterus, and Ovary |
|
|
519 | (6) |
|
|
519 | (1) |
|
|
520 | (1) |
|
|
521 | (2) |
|
|
523 | (2) |
|
Male Reproductive Endocrinology |
|
|
525 | (8) |
|
|
525 | (4) |
|
Primary Gonadal Abnormalities |
|
|
529 | (1) |
|
Defects in Androgen Action |
|
|
529 | (1) |
|
|
529 | (1) |
|
|
529 | (1) |
|
|
530 | (1) |
|
Benign Prostatic Hyperplasia |
|
|
531 | (1) |
|
Carcinoma of the Prostate |
|
|
531 | (2) |
|
|
533 | (13) |
|
|
533 | (2) |
|
|
535 | (1) |
|
|
535 | (1) |
|
|
536 | (3) |
|
|
539 | (7) |
|
|
546 | (7) |
|
Definition of a Low Blood Glucose Level |
|
|
546 | (1) |
|
|
546 | (1) |
|
|
547 | (3) |
|
Diagnostic Work-Up for Hypoglycemia |
|
|
550 | (1) |
|
|
550 | (3) |
Section XI DISEASES OF BONE AND BONE MINERAL METABOLISM |
|
553 | (34) |
|
Normal Physiology of Bone and Bone Minerals |
|
|
555 | (9) |
|
Bone Structure and Metabolism |
|
|
555 | (1) |
|
|
555 | (2) |
|
|
557 | (2) |
|
|
559 | (2) |
|
|
561 | (1) |
|
|
562 | (2) |
|
The Parathyroid Glands, Hypercalcemia, and Hypocalcemia |
|
|
564 | (9) |
|
|
564 | (1) |
|
|
564 | (5) |
|
|
569 | (4) |
|
|
573 | (4) |
|
|
573 | (1) |
|
|
573 | (2) |
|
|
575 | (1) |
|
Laboratory and Radiographic Features |
|
|
575 | (1) |
|
|
576 | (1) |
|
|
576 | (1) |
|
|
577 | (7) |
|
|
577 | (1) |
|
Etiology and Pathogenesis |
|
|
577 | (2) |
|
|
579 | (1) |
|
|
579 | (1) |
|
|
579 | (2) |
|
|
581 | (1) |
|
Glucocorticoid-Induced Bone Loss |
|
|
582 | (2) |
|
|
584 | (3) |
|
|
584 | (1) |
|
|
584 | (1) |
|
Pathology and Pathophysiology |
|
|
584 | (1) |
|
|
584 | (1) |
|
|
585 | (1) |
|
|
585 | (1) |
|
|
585 | (2) |
Sectiion XII MUSCULOSKELETAL AND CONNECTIVE TISSUE DISEASE |
|
587 | (50) |
|
Approach to the Patient with Musculoskeletal Disease |
|
|
589 | (5) |
|
|
589 | (3) |
|
|
592 | (2) |
|
|
594 | (4) |
|
|
594 | (1) |
|
|
594 | (2) |
|
|
596 | (2) |
|
Systemic Lupus Erythematosus |
|
|
598 | (5) |
|
Etiology and Pathogenesis |
|
|
598 | (1) |
|
|
599 | (2) |
|
|
601 | (1) |
|
|
601 | (2) |
|
|
603 | (2) |
|
|
603 | (1) |
|
|
603 | (1) |
|
|
604 | (1) |
|
Idiopathic Inflammatory Myopathies |
|
|
605 | (3) |
|
|
605 | (1) |
|
Diagnostic and Laboratory Findings |
|
|
606 | (1) |
|
|
606 | (2) |
|
Scleroderma (Systemic Sclerosis) |
|
|
608 | (4) |
|
|
608 | (1) |
|
Limited Systemic Sclerosis (CREST Variant) |
|
|
608 | (1) |
|
Diffuse Systemic Sclerosis |
|
|
608 | (1) |
|
Scleroderma Sine Scleroderma |
|
|
608 | (1) |
|
|
608 | (2) |
|
|
610 | (1) |
|
|
611 | (1) |
|
Mixed Connective Tissue Disease, Overlap Syndrome, and Antiphospholipid Antibody Syndrome |
|
|
612 | (2) |
|
Mixed Connective Tissue Disease and Overlap Syndrome |
|
|
612 | (1) |
|
Antiphospholipid Antibody Syndrome |
|
|
612 | (2) |
|
|
614 | (6) |
|
|
614 | (1) |
|
|
614 | (1) |
|
Hypersensitivity Angiitis |
|
|
614 | (1) |
|
|
615 | (1) |
|
Allergic Vasculitis of Churg and Strauss |
|
|
616 | (1) |
|
|
616 | (1) |
|
Polymyalgia Rheumatica and Giant Cell Arteritis |
|
|
617 | (3) |
|
The Spondyloarthropathies |
|
|
620 | (4) |
|
|
620 | (1) |
|
|
621 | (2) |
|
|
623 | (1) |
|
Arthritis Associated with Inflammatory Bowel Disease |
|
|
623 | (1) |
|
|
624 | (3) |
|
|
624 | (1) |
|
Etiology and Pathogenesis |
|
|
624 | (1) |
|
|
624 | (2) |
|
|
626 | (1) |
|
|
626 | (1) |
|
The Crystal-Induced Arthropathies |
|
|
627 | (2) |
|
Chondrocalcinosis and Associated Disorders |
|
|
627 | (2) |
|
Miscellaneous Forms of Arthritis |
|
|
629 | (5) |
|
Musculoskeletal Syndromes Associated with Malignancy |
|
|
629 | (1) |
|
Arthropathies Associated with Endocrine Diseases |
|
|
630 | (1) |
|
Additional Miscellaneous Disorders |
|
|
631 | (3) |
|
|
634 | (3) |
|
|
634 | (1) |
|
|
634 | (1) |
|
|
634 | (1) |
|
|
635 | (2) |
Section XIII INFECTIOUS DISEASE |
|
637 | (144) |
|
Organisms that Infect Humans |
|
|
639 | (6) |
|
|
639 | (1) |
|
|
639 | (1) |
|
|
639 | (1) |
|
|
640 | (1) |
|
|
640 | (2) |
|
|
642 | (1) |
|
|
643 | (1) |
|
|
643 | (2) |
|
Host Defenses Against Infection |
|
|
645 | (8) |
|
Local Barriers to Infection |
|
|
645 | (1) |
|
Components of the Immune System |
|
|
646 | (3) |
|
Nonspecific Effector Mechanisms |
|
|
649 | (1) |
|
Resistance to Extracellur Bacteria |
|
|
650 | (1) |
|
Resistance to Obligate Intracellular Parasites: Viruses |
|
|
651 | (1) |
|
Resistance to Faculative Intracellular Parasites: Mycobacterium Tuberculosis |
|
|
652 | (1) |
|
Laboratory Diagnosis of Infectious Diseases |
|
|
653 | (4) |
|
Diagnosis by Direct Visualization of the Organism |
|
|
653 | (1) |
|
Diagnosis by Detection of Microbial Antigens |
|
|
654 | (1) |
|
Diagnosis by Examination of Host Immune or Inflammatory Responses |
|
|
655 | (1) |
|
Diagnosis by Detection of Microbial Nucleotide Sequences |
|
|
655 | (1) |
|
Diagnosis by Isolation of the Organism in Culture |
|
|
655 | (2) |
|
|
657 | (6) |
|
|
657 | (1) |
|
|
657 | (2) |
|
Characteristics of the Antimicrobial |
|
|
659 | (1) |
|
|
660 | (1) |
|
Monitoring of Antimicrobial Therapy |
|
|
660 | (1) |
|
|
660 | (1) |
|
|
661 | (2) |
|
Fever and Febrile Syndromes |
|
|
663 | (14) |
|
Regulation of Body Temperature |
|
|
663 | (1) |
|
|
663 | (2) |
|
|
665 | (8) |
|
|
673 | (4) |
|
|
677 | (5) |
|
|
677 | (1) |
|
|
678 | (1) |
|
|
679 | (1) |
|
|
680 | (1) |
|
|
680 | (2) |
|
Infections of the Nervous System |
|
|
682 | (11) |
|
|
683 | (5) |
|
|
688 | (2) |
|
Spectrum of Tuberculous, Fungal, and Parasitic Infections |
|
|
690 | (3) |
|
Infections of the Head and Neck |
|
|
693 | (6) |
|
|
693 | (1) |
|
Infections of the Nose and Sinuses |
|
|
693 | (1) |
|
Infections of the Mouth and Pharynx |
|
|
694 | (5) |
|
Infections of the Lower Respiratory Tract |
|
|
699 | (9) |
|
Pathogenesis of Pneumonia |
|
|
699 | (1) |
|
|
699 | (1) |
|
Diagnostic Approach to the Patient |
|
|
700 | (1) |
|
Radiographic Patterns in Patients with Pneumonia |
|
|
700 | (1) |
|
Other Laboratory Findings |
|
|
701 | (1) |
|
Diagnosis and Management of the Patient with Pneumonia |
|
|
701 | (1) |
|
Specific Pathogenic Organisms |
|
|
702 | (3) |
|
|
705 | (2) |
|
|
707 | (1) |
|
Infections of the Heart and Vessels |
|
|
708 | (7) |
|
Infective Endocarditis (IE) |
|
|
708 | (4) |
|
Prosthetic Valve Endocarditis (PVE) |
|
|
712 | (1) |
|
Prophylaxis of Infective Endocarditis |
|
|
712 | (1) |
|
Bacterial Endarteritis and Suppurative Phlebitis |
|
|
713 | (2) |
|
Skin and Soft Tissue Infections |
|
|
715 | (5) |
|
Superficial Infections of the Skin |
|
|
715 | (4) |
|
Deeper Infections of the Skin and Soft Tissue |
|
|
719 | (1) |
|
Intra-Abdominal Abscess and Peritonitis |
|
|
720 | (4) |
|
|
720 | (1) |
|
Abscesses of Solid Organs |
|
|
720 | (2) |
|
|
722 | (1) |
|
|
722 | (2) |
|
Acute Infectious Diarrhea |
|
|
724 | (6) |
|
Pathogenesis and Pathophysiology: General Concepts |
|
|
724 | (1) |
|
Types of Microbial Diarrheal Diseases |
|
|
724 | (2) |
|
General Epidemiologic Considerations |
|
|
726 | (1) |
|
|
727 | (1) |
|
Management: General Principles of Electrolyte Repletion Therapy |
|
|
727 | (3) |
|
Infections Involving Bones and Joints |
|
|
730 | (4) |
|
|
730 | (2) |
|
|
732 | (1) |
|
|
732 | (2) |
|
Infections of the Urinary Tract |
|
|
734 | (3) |
|
|
734 | (1) |
|
Cystitis and Pyelonephritis |
|
|
734 | (2) |
|
|
736 | (1) |
|
|
737 | (4) |
|
Approach to the Hospitalized Patient with Suspected Nosocomial Infection |
|
|
737 | (1) |
|
|
738 | (1) |
|
Intravascular Catheter-Related Infections |
|
|
739 | (1) |
|
|
739 | (1) |
|
Nosocomial Urinary Tract Infection |
|
|
739 | (2) |
|
Sexually Transmitted Diseases |
|
|
741 | (8) |
|
|
741 | (4) |
|
Urethritis, Cervicitis, and Pelvic Inflammatory Disease (PID) |
|
|
745 | (4) |
|
HIV Infection and the Acquired Immunodeficiency Syndrome |
|
|
749 | (20) |
|
|
749 | (2) |
|
|
751 | (2) |
|
Diagnosis and Testing for HIV Infection |
|
|
753 | (2) |
|
Sequential Clinical Manifestations of HIV-1 Infection |
|
|
755 | (1) |
|
Management of HIV Infection |
|
|
756 | (3) |
|
Management of Specific Clinical Manifestations of Immunodeficiency: A Problem-Oriented Approach |
|
|
759 | (1) |
|
|
759 | (2) |
|
|
761 | (2) |
|
|
763 | (1) |
|
Gastrointestinal Diseases |
|
|
764 | (2) |
|
Other Complications of HIV Infection |
|
|
766 | (1) |
|
Prevention of HIV Infection |
|
|
767 | (2) |
|
Infections in the Immunocompromised Host |
|
|
769 | (4) |
|
Disorders of Cell-Mediated Immunity |
|
|
769 | (1) |
|
Disorders of Humoral Immunity |
|
|
769 | (1) |
|
Impaired Neutrophil Function |
|
|
770 | (1) |
|
|
770 | (1) |
|
Diagnostic Problems in the Compromised Host |
|
|
771 | (1) |
|
Prevention and Treatment of Infections in the Neutropenic Patient |
|
|
772 | (1) |
|
Infectious Diseases of Travelers; Protozoal and Helminthic Infections |
|
|
773 | (8) |
|
|
773 | (2) |
|
|
775 | (1) |
|
Protozoal and Helminthic Infections |
|
|
776 | (5) |
Section XIV NEUROLOGIC DISEASE |
|
781 | (148) |
|
Neurologic Evaluation of the Patient |
|
|
783 | (6) |
|
|
783 | (1) |
|
The Neurologic Examination |
|
|
784 | (1) |
|
Diagnostic Tests: Scope and Limitations |
|
|
785 | (4) |
|
Disorders of Consciousness and Higher Brain Function |
|
|
789 | (14) |
|
|
789 | (1) |
|
Pathologic Alterations of Consciousness |
|
|
790 | (6) |
|
Focal Disturbances of Higher Brain Function |
|
|
796 | (3) |
|
|
799 | (4) |
|
Disorders of Mood and Behavior |
|
|
803 | (12) |
|
|
803 | (4) |
|
|
807 | (8) |
|
Disorders of Autonomic Function |
|
|
815 | (3) |
|
|
815 | (2) |
|
Central and Peripheral Autonomic Insufficiencies |
|
|
817 | (1) |
|
Disorders of Sensory Function |
|
|
818 | (21) |
|
Pain and Painful Syndromes |
|
|
818 | (8) |
|
|
826 | (13) |
|
Disorders of the Motor System |
|
|
839 | (19) |
|
Mechanisms of Normal and Abnormal Motor Function |
|
|
839 | (6) |
|
|
845 | (4) |
|
The Major Cerebellar Ataxias |
|
|
849 | (3) |
|
Mechanical Lesions of the Spine and Spinal Cord |
|
|
852 | (6) |
|
|
858 | (16) |
|
Anatomy and Pathophysiology of the Cerebral Circulation |
|
|
858 | (1) |
|
Epidemiology and Risk Factors |
|
|
859 | (1) |
|
|
860 | (8) |
|
Spontaneous Parenchymal Cerebral Hemorrhage |
|
|
868 | (3) |
|
|
871 | (2) |
|
Arteriovenous Malformations (AVMs) |
|
|
873 | (1) |
|
Trauma to the Head and Spine |
|
|
874 | (5) |
|
|
874 | (3) |
|
|
877 | (2) |
|
|
879 | (9) |
|
Incidence and General Etiology |
|
|
879 | (1) |
|
|
879 | (1) |
|
Clinical Seizure Patterns |
|
|
879 | (5) |
|
|
884 | (4) |
|
Intracranial Neoplasms, CNS Complications of Cancer, and States of Altered Intracranial Pressure |
|
|
888 | (10) |
|
|
888 | (5) |
|
|
893 | (1) |
|
|
893 | (2) |
|
Non-Neoplastic Alterations of Intracranial Pressure |
|
|
895 | (3) |
|
Infectious and Inflammatory Disorders of the Nervous System |
|
|
898 | (9) |
|
Bacterial Infections of the Brain |
|
|
898 | (4) |
|
Slow Virus Infections of the Nervous System |
|
|
902 | (1) |
|
Demyelinating and Other CNS Inflammatory Disorders of Probable Immune Cause |
|
|
903 | (4) |
|
Motor Nerve, Nerve Root, Peripheral Nerve, and Neurocutaneous Disorders |
|
|
907 | (14) |
|
Peripheral Nerve Disorders |
|
|
907 | (3) |
|
Mono- and Polyneuropathies Affecting Somatic Cranial Nerve Functions |
|
|
910 | (3) |
|
|
913 | (1) |
|
The Motor Neuron Dieseases |
|
|
913 | (2) |
|
Focal Radiculopathy and Neuropathy |
|
|
915 | (4) |
|
|
919 | (2) |
|
Disorders of Myoneural Junction and Skeletal Muscle |
|
|
921 | (8) |
|
Disorders of Myoneural Junction |
|
|
921 | (2) |
|
Disorders of Skeletal Muscle |
|
|
923 | (6) |
Section XV THE AGING PATIENT |
|
929 | (10) |
|
|
931 | (8) |
|
The Demographics of Aging and Implications for Health Care |
|
|
931 | (2) |
|
Assessment of the Older Patient |
|
|
933 | (2) |
|
Common and Often Inadequately Assessed Medical Problems of the Elderly |
|
|
935 | (4) |
Section XVI SUBSTANCE ABUSE |
|
939 | (12) |
|
Alcohol and Substance Abuse |
|
|
941 | (10) |
|
|
941 | (1) |
|
Tobacco and Alcohol Abuse |
|
|
941 | (4) |
|
|
945 | (2) |
|
|
947 | (4) |
Appendix: Commonly Measured Laboratory Values |
|
951 | (4) |
Index |
|
955 | |